To note, in a previous study on kinome expression profiling of NB tumours, it was observed a marked overexpression of EPHB2 gene in a subset of ultra‐high‐risk NB, with highly aggressive clinical behaviour that not adequately respond to standard treatments.20 This evidence concerns the gene EPHB2 and neuroblastoma.